Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience
Europace · 02.07.2024 · 26 (7)
DOI: 10.1093/europace/euae192 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Europace, online erschienen am 11.07.2024. Verfasst von Petr Peichl und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, IKEM, Vídeňská 1958/9, Praha 4, Prague 140 21, Czechia. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Catheter Ablation, Ventricular Premature Complexes. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Metabolic and Cardiovascular Research, European Union, Ministry of Health.
Abstract (Originalsprache)
Aims
A pulsed electric field (PF) energy source is a novel potential option for catheter ablation of ventricular arrhythmias (VAs) as it can create deeper lesions, particularly in scarred tissue. However, very limited data exist on its efficacy and safety. This prospective observational study reports the initial experience with VA ablation using focal PF. Methods and results The study population consisted of 44 patients (16 women, aged 61 ± 14years) with either frequent ventricular premature complexes (VPCs, 48%) or scar-related ventricular tachycardia (VT, 52%). Ablation was performed using an irrigated 4 mm tip catheter and a commercially available PF generator. On average, 16 ± 15 PF applications (25 A) were delivered per patient. Acute success was achieved in 84% of patients as assessed by elimination of VPC or reaching non-inducibility of VT. In three cases (7%), a transient conduction system block was observed during PF applications remotely from the septum. Root analysis revealed that this event was caused by current leakage from the proximal shaft electrodes in contact with the basal interventricular septum. Acute elimination of VPC was achieved in 81% patients and non-inducibility of VT in 83% patients. At the 3-month follow-up, persistent suppression of the VPC was confirmed on Holter monitoring in 81% patients. In the VT group, the mean follow-up was 116 ± 75 days and a total of 52% patients remained free of any VA.
Conclusion
Pulsed electric field catheter ablation of a broad spectrum of VA is feasible with acute high efficacy; however, the short-term follow-up is less satisfactory for patients with scar-related VT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, IKEM, Vídeňská 1958/9, Praha 4, Prague 140 21, Czechia.
- České Budějovice Hospital and Faculty of Health and Social Sciences, University of South Bohemia in České Budějovice, České Budějovice, Czechia.
ORCID-Profile: Petr Peichl, Alan Bulava, Dan Wichterle, Filip Schlosser, Predrag Stojadinović, Eva Borišincová, Peter Štiavnický, Jana Hašková, Josef Kautzner
Förderung
- National Institute for Metabolic and Cardiovascular Research
- European Union
- Ministry of Health
- IKEM
Zitieren
APA
Peichl, P., Bulava, A., Wichterle, D., Schlosser, F., Stojadinović, P., Borišincová, E., Štiavnický, P., Hašková, J., & Kautzner, J. (2024). Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience. Europace, 26(7). https://doi.org/10.1093/europace/euae192
Vancouver
Peichl P, Bulava A, Wichterle D, Schlosser F, Stojadinović P, Borišincová E, et al. Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience. Europace. 2024;26(7). doi:10.1093/europace/euae192
BibTeX
@article{Peichl2024,
author = {Peichl, Petr and Bulava, Alan and Wichterle, Dan and Schlosser, Filip and Stojadinović, Predrag and Borišincová, Eva and Štiavnický, Peter and Hašková, Jana and Kautzner, Josef},
title = {Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience},
journal = {Europace},
year = {2024},
volume = {26},
number = {7},
doi = {10.1093/europace/euae192}
}
EUVIMED